1 / 4

Head and Neck Cancer Market Observational Studies by Top Companies to 2026

Cancer is the uncontrolled and abnormal growth of cells that results in formation of a mass called tumor. This tumor can be cancerous or benign.

rajbisen
Download Presentation

Head and Neck Cancer Market Observational Studies by Top Companies to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Head and Neck Cancer Head and Neck Cancer Market Size, Share, Trend, Outlook, Future Growth Analysis Trend, Outlook, Future Growth Analysis And Synthesis By 2026 And Synthesis By 2026 Market Size, Share, Cancer is the uncontrolled and abnormal growth of cells that results in formation of a mass called tumor. This tumor can be cancerous or benign. Head and neck cancer is the terminology used to define a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, and mouth. Furthermore, head and neck cancers initiate in squamous cells, cells that line moist surfaces such as those inside the head and neck (for example, the mouth, nose, and throat). Salivary glands have different types of cells that can turn cancerous. Chewing tobacco, excessive alcohol consumption, and infection with human papillomavirus (HPV) increases the risk of head and neck cancer. Other risk factors for head and neck cancers include excessive consumption of paan (betel quid), preserved or salted foods, oral health, occupational exposure, radiation exposure, Epstein barr virus infection, and due to hereditary causes. Request For Sample Copy of This Research: Request For Sample Copy of This Research: https://www.coherentmarketinsights.com/insight/request- https://www.coherentmarketinsights.com/insight/request- sample/530 sample/530 Need for effective and targeted treatment is critical to increase the survival rates Need for effective and targeted treatment is critical to increase the survival rates Treatment of head and neck cancer is a major challenge for physicians, as the affectivity and choice of treatment varies from patient to patient and location of the tumor. Owing to complexity of facial structures and functions limits the surgical treatments for head and neck cancers, with surgery being the preferred mode of treatment. Post-surgery, functions such as chewing, talking, and swallowing may be adversely affected. Physicians opt for surgical therapy in combination with radiation therapy for treatment of the malady. Survival rate of head and neck cancer has reduced from 80% to 50% in last ten years, as currently available treatment options mainly treat the symptoms. Recent developments in the area of advanced chemotherapy and radiotherapy permit preserving some of the functions of the face. The introduction of targeted molecular therapy such as gene therapy, monoclonal antibodies, and antibody drug conjugates creates major growth avenues for the head and neck cancer market.

  2. High incidence rate creates a potential growth opportunity for the market players High incidence rate creates a potential growth opportunity for the market players Growing occurrence of head and neck cancer and increasing research activities to develop cost- effective treatment options are the factors which are driving growth of the global head and neck cancer market. According to the World Health Organization, 3 - 5% of the population around the globe suffers from head and neck cancer. Moreover, worldwide approximately 550,000 new cases of head and neck cancer are diagnosed annually with almost 300,000 deaths annually. While the cancer can affect people across different age groups, it is especially prevalent among people over 50 years of age. Head and neck cancer is projected to result in 13,360 fatalities (3,420 women and 9,940 men) in 2017. These types of cancers are more than twice as common among men as women. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Head and Neck Cancer Market Research Objective and Assumption • Head and Neck Cancer Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Head and Neck Cancer Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Head and Neck Cancer Market, By Regions • Head and Neck Cancer Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Head and Neck Cancer Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Head and Neck Cancer Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Head and Neck Cancer Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion

  3. Global Top Players - Global Top Players - Key players operating in the head and neck cancer market are AB Science SA, Bayer AG, Bristol-Myers Squibb Company, Acceleron Pharma, Inc., Astellas Pharma Inc., Boston Biomedical, Inc., AbbVie Inc., and AstraZeneca Plc. Head And Neck Cancer Market Taxonomy - Head And Neck Cancer Market Taxonomy - On the basis of disease indication, the global head and neck cancer market is classified into: On the basis of disease indication, the global head and neck cancer market is classified into: Laryngeal and Hypopharyngeal Cancer • Nasal Cavity and Paranasal Sinus Cancer • Nasopharyngeal Cancer • Oral and Oropharyngeal Cancer • Salivary Gland Cancer • On the basis of diagnostic methods, the global head and neck cancer market is classified into: On the basis of diagnostic methods, the global head and neck cancer market is classified into: Diagnostic imaging equipment • Endoscopy screening equipment • Bioscopy screening tests • Blood tests • Dental diagnostic • Browse Full Research Report @ Browse Full Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/head- https://www.coherentmarketinsights.com/ongoing-insight/head- and-neck-cancer-market-530 and-neck-cancer-market-530

  4. About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com

More Related